145 related articles for article (PubMed ID: 9207404)
1. Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assay.
Astori C; Bonfichi M; Pagnucco G; Bernasconi P; Lazzarino M; Orlandi E; Bernasconi C
Br J Haematol; 1997 Jun; 97(3):586-8. PubMed ID: 9207404
[TBL] [Abstract][Full Text] [Related]
2. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria.
Hillmen P; Hows JM; Luzzatto L
Br J Haematol; 1992 Mar; 80(3):399-405. PubMed ID: 1374629
[TBL] [Abstract][Full Text] [Related]
3. Correction of the PNH defect by GPI-anchored protein transfer.
Sloand EM; Maciejewski JP; Dunn D; Moss J; Brewer B; Kirby M; Young NS
Blood; 1998 Dec; 92(11):4439-45. PubMed ID: 9834251
[TBL] [Abstract][Full Text] [Related]
4. Glycosylphosphatidyl-inositol (GPI)-linked protein deficiency on the platelets of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria: two distinct patterns correlating with expression on neutrophils.
Jin JY; Tooze JA; Marsh JC; Gordon-Smith EC
Br J Haematol; 1997 Mar; 96(3):493-6. PubMed ID: 9054654
[TBL] [Abstract][Full Text] [Related]
5. Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies.
Navenot JM; Bernard D; Harousseau JL; Muller JY; Blanchard D
Leuk Lymphoma; 1996 Mar; 21(1-2):143-51. PubMed ID: 8907282
[TBL] [Abstract][Full Text] [Related]
6. Paroxysmal nocturnal haemoglobinuria.
Hill A; DeZern AE; Kinoshita T; Brodsky RA
Nat Rev Dis Primers; 2017 May; 3():17028. PubMed ID: 28516949
[TBL] [Abstract][Full Text] [Related]
7. A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes.
Oelschlaegel U; Besson I; Arnoulet C; Sainty D; Nowak R; Naumann R; Bux Y; Ehninger G
Clin Lab Haematol; 2001 Apr; 23(2):81-90. PubMed ID: 11488846
[TBL] [Abstract][Full Text] [Related]
8. Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after erythrocyte transfusion in paroxysmal nocturnal hemoglobinuria.
Sloand EM; Mainwaring L; Keyvanfar K; Chen J; Maciejewski J; Klein HG; Young NS
Blood; 2004 Dec; 104(12):3782-8. PubMed ID: 15304386
[TBL] [Abstract][Full Text] [Related]
9. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
Yuan FF; Bryant JA; Fletcher A
Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
[TBL] [Abstract][Full Text] [Related]
10. Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during In vitro maturation of reticulocytes.
Rabesandratana H; Toutant JP; Reggio H; Vidal M
Blood; 1998 Apr; 91(7):2573-80. PubMed ID: 9516159
[TBL] [Abstract][Full Text] [Related]
11. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
[TBL] [Abstract][Full Text] [Related]
13. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes.
Navenot JM; Muller JY; Blanchard D
Transfusion; 1998 Apr; 38(4):337-42. PubMed ID: 9595015
[TBL] [Abstract][Full Text] [Related]
15. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H
Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry and immunoblotting analysis of monoclonal antibodies directed to complement regulatory proteins.
Blanchard D; Navenot JM; Petit-Le Roux Y; Willem C; Loirat MJ
Transfus Clin Biol; 1997; 4(1):131-4. PubMed ID: 9095519
[TBL] [Abstract][Full Text] [Related]
17. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
Fujioka S; Yamada T
Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
[TBL] [Abstract][Full Text] [Related]
18. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats.
Wang SA; Pozdnyakova O; Jorgensen JL; Medeiros LJ; Stachurski D; Anderson M; Raza A; Woda BA
Haematologica; 2009 Jan; 94(1):29-37. PubMed ID: 19001281
[TBL] [Abstract][Full Text] [Related]
19. [Rapid diagnosis of paroxysmal nocturnal hemoglobinuria by gel test agglutination].
Navenot JM; Bernard D; Petit-Frioux Y; Loirat MJ; Guimbretière J; Muller JY; Blanchard D
Rev Fr Transfus Hemobiol; 1993 Apr; 36(2):135-47. PubMed ID: 7684909
[TBL] [Abstract][Full Text] [Related]
20. Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria.
Terstappen LW; Nguyen M; Huang S; Lazarus HM; Medof ME
Br J Haematol; 1993 Jul; 84(3):504-14. PubMed ID: 7692931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
